Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal

Gastrointestinal Cancer Research

Volumn 6, Issue 2, 2013, Pages 39-45

  Chuong, Michael D ^a   Freilich, Jessica M ^a   Hoffe, Sarah E ^a   Fulp, William ^a   Weber, Jill M ^b   Almhanna, Khaldoun ^b   Dinwoodie, William ^b   Rao, Nikhil ^a   Meredith, Kenneth L ^b   Shridhar, Ravi ^a  

^a Department of Radiation Oncology ^*  (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEMIA; ANUS SQUAMOUS CELL CARCINOMA; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; COLOSTOMY FREE SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL; UROGENITAL TRACT DISEASE;

EID: 84878878284     PISSN: 19347820     EISSN: 19347987     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nigro N, Seydel H, Considine B, et al: Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51:1826-1829, 1983
2. UK Co-ordinating Committee on Cancer Research: Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. Lancet 348:1049-1054, 1996
3. Bartelink H, Roelofsen F, Eschwege F, et al: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:1049-2040, 1997
4. Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299:1914-1921, 2008
5. NCCN Guidelines for Anal Carcinoma, version 2.2013. Fort Washington, PA: National Comprehensive Cancer Network, 2013 http://www.nccn.org/professionals/physician_gls/pdf/anal.pdf
6. Milano MT, Jani AB, Farrey KJ, et al: Intensitymodulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63:354-361, 2005
7. Salama JK, Mell LK, Schomas DA, et al: Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 25:4581-4586, 2007
8. Pepek JM, Willett CG, Wu QJ, et al: Intensitymodulated radiation therapy for anal malignan-cies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys 78:1413-1419, 2010
9. Kachnic LA, Tsai HK, Coen JJ, et al. Dosepainted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys 82:153-158, 2012
10. Kachnic LA, Winter KA, Myerson R, et al. Twoyear outcomes of RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. J Clin Oncol 29:(suppl 4), 2011 (abstr 368)
11. Bazan JG, Hara W, Hsu A, et al: Intensitymodulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer 117:3342-3351, 2011
12. Chuong MD, Hoffe SE, Weber J, et al: Outcomes of anal cancer treated with definitive IMRT-based chemoradiation. J Radiat Oncol 1:165-172, 2012
13. Kachnic LA, Winter K, Myerson RJ, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys Epub ahead of print, November 10, 2012
14. Menkarios C, Azria D, Laliberte B, et al: Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 2:165-41, 2007
15. Chen YJ, Liu A, Tsai PT, et al: Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Radiat Oncol Biol Phys 63:274-281, 2005
16. Greene FL, Page DL, Fleming ID, et al: Cancer Staging Manual (ed 6) New York: Springer, 2002
17. Roohipour R, Patil S, Goodman KA, et al: Squamous-cell carcinoma of the anal canal: predic-tors of treatment outcome. Dis Colon Rectum 51:147-153, 2008
18. Ben-Josef E, Moughan J, Ajani JA, et al: Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. J Clin Oncol 28:5061-5066, 2010
19. Meyer A, Meier Zu Eissen J, et al: Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome. Acta Oncol 45;728-735, 2006